Kyverna Therapeutics
We are a Phase 2 clinical biopharmaceutical company (biotech) developing cell therapies for patients suffering from autoimmune diseases. Our initial focus is on lupus nephritis (LN) and systemic sclerosis (SSc). (Incorporated in Delaware) We are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our goal is to […]
January 17, 2024 Read More